Evaluation of reverse transcriptase and protease inhibitors in two-drug combinations against human immunodeficiency virus replication.

Documenti analoghi

• Characterization of siamycin I, a human immunodeficiency virus fusion inhibitor.
  di: Lin, P F, et al.
  Pubblicazione: (1996)
• Nonnucleoside reverse transcriptase inhibitors that potently and specifically block human immunodeficiency virus type 1 replication.
  di: Romero, D L, et al.
  Pubblicazione: (1991)
• Human immunodeficiency virus type 1 viral background plays a major role in development of resistance to protease inhibitors.
  di: Rose, R E, et al.
  Pubblicazione: (1996)
• Combinative interactions of a human immunodeficiency virus (HIV) Tat antagonist with HIV reverse transcriptase inhibitors and an HIV protease inhibitor.
  di: Connell, E V, et al.
  Pubblicazione: (1994)
• Human Immunodeficiency Virus Reverse Transcriptase and Protease Sequence Database
  di: Shafer, Robert W., et al.
  Pubblicazione: (2000)